Mollie Sue Schubert is a prominent inventor based in Cedar Rapids, IA (US). She has made significant contributions to the field of biotechnology, particularly in the development of CRISPR technology. With a total of 3 patents, her work focuses on enhancing the efficiency and effectiveness of CRISPR systems.

Latest Patents

One of her latest patents involves CRISPR-based compositions and methods of use. This invention pertains to modified compositions for use in CRISPR systems and their methods of use. In particular, length-modified and chemically-modified forms of crRNA and tracrRNA are described for use as a reconstituted guide RNA for interaction with Cas9 of CRISPR systems. The resultant length-modified and chemically-modified forms of crRNA and tracrRNA are economical to produce and can be tailored to have unique properties relevant to their biochemical and biological activity in the context of the CRISPR Cas9 endonuclease system.

Career Highlights

Mollie Sue Schubert is currently employed at Integrated DNA Technologies, Inc. Her innovative work has positioned her as a key player in the advancement of genetic engineering technologies. Her patents reflect her commitment to improving CRISPR methodologies, which have vast implications for research and therapeutic applications.

Collaborations

Mollie has collaborated with notable coworkers, including Michael Allen Collingwood and Ashley Mae Jacobi. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking technologies in the field.

Conclusion

Mollie Sue Schubert's contributions to CRISPR technology exemplify her dedication to innovation in biotechnology. Her patents and collaborations highlight her role as a leading inventor in this transformative field.

This text is generated by artificial intelligence and may not be accurate.